719d4cd319a54ca01b36c63073e0b89c.jpg

Next Events

Clinical trial to test potential new combination therapy for aggressive breast cancer

Events & Seminars

test2-2500.png

Information

And Paradoxically, a gene variant that increases inflammation also has a protective effect on the kidneys. Seen here, kidney cell nuclei (blue) and an influx of immune regulatory cells (pink) that prevent damage in an injured kidney. (Credit: Garvan)

test-ratios.png

Location description - Donec morbi feugiat curae ac ultrices fringilla aenean dapibus.

Summary Sodales condimentum ipsum condimentum pulvinar euismod parturient adipiscing.

Logos title

Cards 1

Natoque morbi parturient condimentum in ac ullamcorper ridiculus.

Cards 2

Summary Class consectetur ridiculus ultricies accumsan ad dolor est.

Icon Cards Title

Item 1

Item 2

Summary A habitant nulla himenaeos commodo scelerisque nullam suscipit augue.

Accordion

Resource title

Triple negative breast cancer is an aggressive disease with a greater likelihood of spreading around the body and recurring within five years than other breast cancers.

Explore our research

Research at Garvan

Discover Our Impact

Our impact

Our people

Our people

News & resources

News & resources

About us

About us

Support our research test

Events & Seminars

Previous Events

Test Revolutionising triple negative breast cancer treatment

TF Test Event

Revolutionising triple negative breast cancer treatment

Bite Size Science Seminar 3: Accelerating genomic diagnosis of disease

Annual Breast Cancer Seminar: From the Lab to you

Harnessing genomics for families with inherited heart diseases